Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Wizel

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniaeIrina Pinchuk, Barry C Starcher, Brian Livingston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogenBenjamin Wizel, Barry C Starcher, Buka Samten, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacteriumRamakrishna Vankayalapati, Benjamin Wizel, Stephen E Weis, et al.
Plos One|February 14, 2013
The two-component adjuvant IC31® boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRsAttila Szabo, Peter Gogolak, Kitti Pazmandi, et al.
FEMS Immunology and Medical Microbiology|May 3, 2003
The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytesHomayoun Shams, Benjamin Wizel, David L Lakey, et al.
Vaccines|January 28, 2026
Compatibility and Stability of a <i>Shigella</i> Polysaccharide-Protein Conjugate Antigen Formulated with Aluminum Salt and CpG 1018<sup>®</sup> AdjuvantsPoorva Taskar, Prashant Kumar, Brandy Dotson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
CD40 ligand trimer enhances the response of CD8+ T cells to Mycobacterium tuberculosisBuka Samten, Benjamin Wizel, Homayoun Shams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA allelesHomayoun Shams, Peter Klucar, Steven E Weis, et al.
Molecular Microbiology|March 11, 2004
The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivoShiping Wu, Susan T Howard, David L Lakey, et al.
Human Vaccines & Immunotherapeutics|February 4, 2025
PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studiesJohn M Hickey, Nitya Sharma, Max Fairlamb, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniaeIrina Pinchuk, Barry C Starcher, Brian Livingston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogenBenjamin Wizel, Barry C Starcher, Buka Samten, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacteriumRamakrishna Vankayalapati, Benjamin Wizel, Stephen E Weis, et al.
Plos One|February 14, 2013
The two-component adjuvant IC31® boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRsAttila Szabo, Peter Gogolak, Kitti Pazmandi, et al.
FEMS Immunology and Medical Microbiology|May 3, 2003
The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytesHomayoun Shams, Benjamin Wizel, David L Lakey, et al.
Vaccines|January 28, 2026
Compatibility and Stability of a <i>Shigella</i> Polysaccharide-Protein Conjugate Antigen Formulated with Aluminum Salt and CpG 1018<sup>®</sup> AdjuvantsPoorva Taskar, Prashant Kumar, Brandy Dotson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
CD40 ligand trimer enhances the response of CD8+ T cells to Mycobacterium tuberculosisBuka Samten, Benjamin Wizel, Homayoun Shams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA allelesHomayoun Shams, Peter Klucar, Steven E Weis, et al.
Molecular Microbiology|March 11, 2004
The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivoShiping Wu, Susan T Howard, David L Lakey, et al.
Human Vaccines & Immunotherapeutics|February 4, 2025
PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studiesJohn M Hickey, Nitya Sharma, Max Fairlamb, et al.
Pageof 3